ACHE and Alzheimer disease: Moreover, the exogenous administration of a synthetic version of the AChE-peptide drives an influx of calcium with eventual, secondary production of Aβ and Tau phosphorylation [15,17] through its interaction with the α7-nAChR [10], ultimately instigating a familiar cascade of pathological events characterizing AD.